134 related articles for article (PubMed ID: 14533192)
1. Modulation of renal glomerular disease using remote delivery of adenoviral-encoded solubletype II TGF-beta receptor fusion molecule.
Haviv YS; Takayama K; Nagi PA; Tousson A; Cook W; Wang M; Lam JT; Naito S; Lei X; Carey DE; Curiel DT
J Gene Med; 2003 Oct; 5(10):839-851. PubMed ID: 14533192
[TBL] [Abstract][Full Text] [Related]
2. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K
Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399
[TBL] [Abstract][Full Text] [Related]
4. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
5. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
6. A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats.
Ueno H; Sakamoto T; Nakamura T; Qi Z; Astuchi N; Takeshita A; Shimizu K; Ohashi H
Hum Gene Ther; 2000 Jan; 11(1):33-42. PubMed ID: 10646637
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice.
Nagashio Y; Ueno H; Imamura M; Asaumi H; Watanabe S; Yamaguchi T; Taguchi M; Tashiro M; Otsuki M
Lab Invest; 2004 Dec; 84(12):1610-8. PubMed ID: 15502860
[TBL] [Abstract][Full Text] [Related]
9. A COL1A1 Promoter-Controlled Expression of TGF-β Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
Zhang S; Gong Y; Xiao J; Chai Y; Lei J; Huang H; Xiang T; Shen W
Dig Dis Sci; 2018 Oct; 63(10):2662-2672. PubMed ID: 29934723
[TBL] [Abstract][Full Text] [Related]
10. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.
Qi Z; Atsuchi N; Ooshima A; Takeshita A; Ueno H
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2345-9. PubMed ID: 10051644
[TBL] [Abstract][Full Text] [Related]
11. Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.
Neelisetty S; Alford C; Reynolds K; Woodbury L; Nlandu-Khodo S; Yang H; Fogo AB; Hao CM; Harris RC; Zent R; Gewin L
Kidney Int; 2015 Sep; 88(3):503-14. PubMed ID: 25760325
[TBL] [Abstract][Full Text] [Related]
12. Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.
Chung IM; Kim J; Pak YK; Jang Y; Yang WI; Han I; Park SJ; Park SW; Huh J; Wight TN; Ueno H
Int J Cardiol; 2010 Dec; 145(3):468-75. PubMed ID: 20053468
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis.
Shen N; Lin H; Wu T; Wang D; Wang W; Xie H; Zhang J; Feng Z
Kidney Int; 2013 Jul; 84(1):64-77. PubMed ID: 23486519
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
[TBL] [Abstract][Full Text] [Related]
15. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure.
Okada H; Takemura G; Kosai K; Li Y; Takahashi T; Esaki M; Yuge K; Miyata S; Maruyama R; Mikami A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2005 May; 111(19):2430-7. PubMed ID: 15867170
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic amelioration of fibroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector.
Nishioka A; Ogawa Y; Mima T; Jin YJ; Sonobe H; Kariya S; Kubota K; Yoshida S; Ueno H
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1235-41. PubMed ID: 15001268
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Isaka Y; Akagi Y; Ando Y; Tsujie M; Sudo T; Ohno N; Border WA; Noble NA; Kaneda Y; Hori M; Imai E
Kidney Int; 1999 Feb; 55(2):465-75. PubMed ID: 9987071
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion.
Mehrara BJ; Spector JA; Greenwald JA; Ueno H; Longaker MT
Plast Reconstr Surg; 2002 Aug; 110(2):506-14. PubMed ID: 12142669
[TBL] [Abstract][Full Text] [Related]
20. Photocoagulation-induced retinal gliosis is inhibited by systemically expressed soluble TGF-beta receptor type II via adenovirus mediated gene transfer.
Hisatomi T; Sakamoto T; Yamanaka I; Sassa Y; Kubota T; Ueno H; Ohnishi Y; Ishibashi T
Lab Invest; 2002 Jul; 82(7):863-70. PubMed ID: 12118088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
